Balentine LLC’s Artivion AORT Stock Holding History

Balentine LLC’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-53	Closed	-$1K	–	89
2017 Q4	$1K	Hold	53	–	–	﹤0.01%	610
2017 Q3	$1K	Hold	53	–	–	﹤0.01%	623
2017 Q2	$1K	Hold	53	–	–	﹤0.01%	595
2017 Q1	$1K	Buy	+53	New	+$936	﹤0.01%	563

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Balentine LLC's AORT Position: Q1 2018 in Review

Balentine LLC sold out of Artivion (AORT) in Q1 2018, closing a stake of 53 shares — an estimated $1K sold.

Balentine LLC first reported a position in AORT in Q1 2017 and held it in 4 quarters. The position peaked at $1K in Q4 2017. 114 funds tracked by Wall St. Rank hold AORT as of Q1 2018.

Balentine LLC reported no remaining Artivion position as of Q1 2018 after selling out during the quarter.
Balentine LLC sold 53 Artivion shares in Q1 2018, an estimated $1K.
Balentine LLC first reported a position in Artivion in Q1 2017 and held it in 4 quarters.
Balentine LLC's Artivion position peaked at $1K in Q4 2017.
114 funds tracked by Wall St. Rank held Artivion as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.